RxDoctor Payments Data

Dimitris Placantonakis, MD

Neurological Surgery · New York, NYNPI 1174780498

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,363 of the $12,441 with a category attached, or 67.2%. Servier Pharmaceuticals LLC accounts for 73.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,320 and has fallen 99.8% since, to $18 in 2025.

$12,441in general payments, 2019–2025

Across 24 payments — averaging $518.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$9K
  • Monteris Medical Corporation$3K
  • Stryker$132
  • Leica Microsystems (schweiz) AG$123
  • AbbVie$61
  • Synaptive Medical Inc.$56
$24,528in research payments, 2019–2025

Across 13 payments — averaging $1886.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$25K

What the payments were for

  • Consulting fees$8,36367%
  • Speaking & faculty fees$1,50012%
  • Travel & lodging$1,34411%
  • Food & beverage$1,23410%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Servier Pharmaceuticals LLC4$9,100
Monteris Medical Corporation14$2,969
Stryker1$132
Leica Microsystems (schweiz) AG1$123
AbbVie3$61
Synaptive Medical Inc.1$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,441 in reported general payments places this provider in the 70th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024
$76,617
Medicare patients
97
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →